Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

NCT00874315 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of accrual

Conditions

Neuroblastoma

Interventions

OTHER: anti-thymocyte globulin
DRUG: busulfan
DRUG: cyclosporine
DRUG: fludarabine phosphate
DRUG: mycophenolate mofetil
DRUG: tacrolimus
PROCEDURE: allogeneic hematopoietic stem cell transplantation

Sponsor

Nationwide Children's Hospital